Evidence map›Paper›PMID 37623969›Full record

ArticlePathogens (Basel, Switzerland)2023

Factors Associated with Carriage of Enteropathogenic and Non-Enteropathogenic Viruses: A Reanalysis of Matched Case-Control Data from the AFRIBIOTA Site in Antananarivo, Madagascar.

Iony Manitra Razanajatovo, Lova Andrianomiadana, Azimdine Habib, Mirella Malala Randrianarisoa, Helisoa Razafimanjato, Maheninasy Rakotondrainipiana, Prisca Andriantsalama, Ravaka Randriamparany, Soa Fy Andriamandimby, Pascale Vonaesch and 6 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Iony Manitra RazanajatovoVirology Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.ORCID 0000-0002-8376-1053
Lova AndrianomiadanaExperimental Bacteriology Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.
Azimdine HabibExperimental Bacteriology Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.ORCID 0000-0001-9108-9167
Mirella Malala RandrianarisoaEpidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.
Helisoa RazafimanjatoVirology Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.
Maheninasy RakotondrainipianaEpidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.
Prisca AndriantsalamaEpidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.
Ravaka RandriamparanyEpidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.
Soa Fy AndriamandimbyVirology Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.
Pascale VonaeschDepartment of Fundamental Microbiology, University of Lausanne, 1002 Lausanne, Switzerland.ORCID 0000-0002-1064-6505
Philippe Jean SansonettiChaire de Microbiologie et Maladies Infectieuses, Collège de France, 75000 Paris, France.
Vincent LacosteVirology Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.ORCID 0000-0002-3173-4053
Rindra Vatosoa RandremananaEpidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.ORCID 0000-0002-6174-8827
Jean-Marc CollardExperimental Bacteriology Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.ORCID 0000-0002-1490-3978
Jean-Michel HeraudVirology Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.ORCID 0000-0003-1107-0859
On Behalf Of The Afribiota Investigators

Funding

Institut Pasteur AfribiotaOdyssey Re-Insurance company AfribiotaPasteur Foundation Switzerland AfribiotaTotal Corporate Foundation Afribiota
6 · The paper itself

Abstract

Environmental Enteric Dysfunction (EED) is an associate driver of stunting in poor settings, and intestinal infections indirectly contribute to the pathophysiology underlying EED. Our work aimed at assessing whether enteric viral carriage is determinant to stunting. A total of 464 healthy and asymptomatic children, aged 2 to 5 years, were recruited, and classified as non-stunted, moderately stunted, or severely stunted. Among the recruited children, 329 stool samples were obtained and screened for enteric and non-enteric viruses by real-time polymerase chain reaction. We statistically tested for the associations between enteric viral and potential risk factors. Approximately 51.7% of the stool samples were positive for at least one virus and 40.7% were positive for non-enteric adenoviruses. No statistical difference was observed between virus prevalence and the growth status of the children. We did not find any statistically significant association between viral infection and most of the socio-demographic risk factors studied, except for having an inadequate food quality score or an over-nourished mother. In addition, being positive for

Indexed as

Africaenteric virusesMadagascarstunting

Identifiers

PMID37623969
PMCPMC10459613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.